Pascal Soriot, AstraZeneca CEO (Raphael Lafargue/Abaca/Sipa USA; Sipa via AP Images)

November 5, 2020 07:12 AM ESTUpdated 10:35 AM

Covid-19 roundup: Soriot — vaccine could be ready by year's end; WHO omits remdesivir from developing countries plan

Max Gelman

Senior Editor

AstraZeneca’s Covid-19 vaccine could be ready for large-scale distribution by the end of this year, CEO Pascal Soriot said in an interview Thursday morning. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Soriot — vaccine could be ready by year's end; WHO omits remdesivir from developing countries plan

Max Gelman

Senior Editor

Sign up to read this article for free.

Trump taps Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, surgeon general picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

ADC biotech Adcendo nabs $135M Series B as it enters the clinic

Senate Judiciary Committee advances patent bill with new protections for pharma challenges

From vaccines to psychedelics, five drugmakers on what could change under a Trump administration

Covid-19 roundup: So­ri­ot — vac­cine could be ready by year's end; WHO omits remde­sivir from de­vel­op­ing coun­tries plan

Max Gelman

Senior Editor

Sign up to read this article for free.

more like this

Trump taps Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, sur­geon gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

ADC biotech Ad­cen­do nabs $135M Se­ries B as it en­ters the clin­ic

Sen­ate Ju­di­cia­ry Com­mit­tee ad­vances patent bill with new pro­tec­tions for phar­ma chal­lenges

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

Covid-19 roundup: Soriot — vaccine could be ready by year's end; WHO omits remdesivir from developing countries plan

Trump taps Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, surgeon general picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

ADC biotech Adcendo nabs $135M Series B as it enters the clinic

Senate Judiciary Committee advances patent bill with new protections for pharma challenges

From vaccines to psychedelics, five drugmakers on what could change under a Trump administration